Step by Stepa HemeOncBuddy patient portal

Busulfan

Illustration: Busulfan

Say it: byoo-SULL-fan · Brand names: Myleran, Busulfex

Busulfan is a chemotherapy medicine that damages the DNA in blood-forming cells, often used to prepare for a stem cell transplant.

What it is

Busulfan links the strands of DNA together so cells cannot copy themselves. It works strongly on cells in the bone marrow. This clears space for new stem cells during a transplant.

Often used for

How you get it

Before a transplant, busulfan is given through a vein (IV), often every 6 hours or once a day for 4 days, in the hospital. A pill form may be taken at home for chronic myeloid leukemia. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Side effect guides

Sources

Quick answers

What is Busulfan?
Busulfan is a chemotherapy medicine that damages the DNA in blood-forming cells, often used to prepare for a stem cell transplant. Brand names: Myleran, Busulfex.
What is Busulfan used for?
preparing the body for a stem cell transplant; chronic myeloid leukemia (CML).
How is Busulfan given?
Before a transplant, busulfan is given through a vein (IV), often every 6 hours or once a day for 4 days, in the hospital. A pill form may be taken at home for chronic myeloid leukemia. Your schedule may be different.
What are the common side effects of Busulfan?
Very low blood counts, which raise your risk of infection, bleeding, and tiredness. Nausea and vomiting. Mouth sores. Diarrhea. Poor appetite. Hair loss. Darker skin.
When should I call my care team while taking Busulfan?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills; A seizure, shaking, or sudden confusion; Fast weight gain, belly swelling, or pain under the right ribs; Yellow skin or eyes; A new cough or shortness of breath; Bleeding or bruising that will not stop, black or bloody stools, or blood in your urine.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.